Atanasković-Marković Marina, Velicković Tanja Cirković, Gavrović-Jankulović Marija, Vucković Olja, Nestorović Branimir
Department of Allergology and Pulmonology, University Children's Hospital, Belgrade, Serbia and Montenegro.
Pediatr Allergy Immunol. 2005 Jun;16(4):341-7. doi: 10.1111/j.1399-3038.2005.00280.x.
Penicillins and cephalosporins are the most important betalactams inducing IgE-mediated reactions. The safety of administering cephalosporins to penicillin-allergic children is a particular problem, because cephalosporin allergenic determinants have not been properly identified. A study was undertaken to evaluate the frequency of anaphylactic reactions to cephalosporins and penicillins and their cross-reactivity in a pediatric population. A prospective survey was conducted in a group of 1170 children with suspected immediate allergic reactions to cephalosporins and/or penicillins, which were examined during a period of 8 yr. In vivo (skin tests and challenges) and in vitro tests (for specific IgE) were performed with standard concentration of penicillins and cephalosporins. When 1170 children with a clinical history of allergy to penicillins and/or cephalosporins were tested in vivo for immediate hypersensitivity to betalactams, 58.3% cases overall were found to be skin or challenge test positive. Among them, 94.4% patients were positive to penicillins and 35.3% to cephalosporins. The frequency of positive reactions in the in vivo testing was in the range from 36.4% to 88.1% for penicillins and from 0.3% to 29.2% for cephalosporins. However, 31.5% of the penicillin allergic children cross-reacted to some cephalosporin. If a child was allergic to a cephalosporin, the frequency of positive reactions to penicillin was 84.2%. The cross-reactivity between cephalosporins and penicillins varied between 0.3% and 23.9%. The cross-reactivity among different generations of cephalosporins varied between 0% and 68.8%, being the highest for first and second-generation cephalosporins and 0% for third generation cephalosporins. The frequency of immediate allergic reactions to cephalosporins is considerably lower compared to penicillins, and the degree of cross-reactivity between cephalosporins and penicillins depends on the generation of cephalosporins, being higher with earlier generation cephalosporins. The cross-reactivity among cephalosporins is lower compared to cross-reactivity between penicillins and cephalosporins.
青霉素和头孢菌素是引发IgE介导反应的最重要的β-内酰胺类药物。对青霉素过敏的儿童使用头孢菌素的安全性是一个特殊问题,因为头孢菌素的过敏原决定簇尚未得到恰当识别。开展了一项研究,以评估儿科人群中对头孢菌素和青霉素过敏反应的发生率及其交叉反应性。对一组1170名疑似对头孢菌素和/或青霉素有速发型过敏反应的儿童进行了一项前瞻性调查,这些儿童在8年期间接受了检查。使用标准浓度的青霉素和头孢菌素进行体内试验(皮肤试验和激发试验)和体外试验(检测特异性IgE)。当对1170名有青霉素和/或头孢菌素过敏临床病史的儿童进行体内β-内酰胺类药物速发型超敏反应检测时,总体上58.3%的病例皮肤试验或激发试验呈阳性。其中,94.4%的患者对青霉素呈阳性,35.3%对头孢菌素呈阳性。青霉素体内试验阳性反应的发生率在36.4%至88.1%之间,头孢菌素在0.3%至29.2%之间。然而,31.5%的青霉素过敏儿童对某些头孢菌素有交叉反应。如果一名儿童对头孢菌素过敏,对青霉素阳性反应的发生率为84.2%。头孢菌素与青霉素之间的交叉反应性在0.3%至23.9%之间。不同代头孢菌素之间的交叉反应性在0%至68.8%之间,第一代和第二代头孢菌素最高,第三代头孢菌素为0%。与青霉素相比,对头孢菌素速发型过敏反应的发生率要低得多,头孢菌素与青霉素之间的交叉反应程度取决于头孢菌素的代次,早期代次的头孢菌素交叉反应性更高。头孢菌素之间的交叉反应性低于青霉素与头孢菌素之间的交叉反应性。